News

Rheumatoid arthritis is a painful and disabling autoimmune disease that affects more than 1% of people worldwide. In the ...
Functional MRI studies have established that subjective feelings of pain and fatigue have objective correlates in terms of ...
In a large-scale, longitudinal study published in ERJ Open Research, researchers have found that individuals with rheumatoid ...
A recent study published in Engineering has shed light on a novel combination therapy for rheumatoid arthritis (RA) that ...
Telitacicept is approved in China for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and generalized myasthenia gravis (gMG). A global Phase 3 clinical trial in gMG is currently ...
A population-based cross-sectional study published in Clinical Rheumatology reveals that individuals with rheumatoid ...
The most comprehensive analysis of rheumatoid arthritis data to date reveals that demographic changes and uneven health ...
Rheumatoid arthritis (RA) has steadily increased around the world during the past three decades, a new AI-powered study ...
A groundbreaking AI-powered study reveals a significant surge in global rheumatoid arthritis cases since 1980.
Sustained remission at 10 years was more common as well among the patients starting anti-TNFs right away, Toyoda told ...